{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T09:29:46Z","timestamp":1793179786796,"version":"4.5.0"},"reference-count":68,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"vor","delay-in-days":365,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100018936","name":"Universit\u00e4tsklinikum Heidelberg","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100018936","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001661","name":"Heidelberg University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001661","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["gimjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Genetics in Medicine"],"published-print":{"date-parts":[[2022,4]]},"DOI":"10.1016\/j.gim.2021.12.008","type":"journal-article","created":{"date-parts":[[2022,1,19]],"date-time":"2022-01-19T12:50:31Z","timestamp":1642596631000},"page":"931-954","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":24,"title":["A practical guide to interpreting germline variants that drive hematopoietic malignancies, bone marrow failure, and chronic cytopenias"],"prefix":"10.1016","volume":"24","author":[{"given":"Simone","family":"Feurstein","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher N.","family":"Hahn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nikita","family":"Mehta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucy A.","family":"Godley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.gim.2021.12.008_bib1","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1038\/gim.2015.30","article-title":"Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology","volume":"17","author":"Richards","year":"2015","journal-title":"Genet Med"},{"issue":"12","key":"10.1016\/j.gim.2021.12.008_bib2","doi-asserted-by":"crossref","first-page":"1687","DOI":"10.1038\/gim.2018.42","article-title":"ClinGen Sequence Variant Interpretation Working Group. The ACMG\/AMP reputable source criteria for the interpretation of sequence variants","volume":"20","author":"Biesecker","year":"2018","journal-title":"Genet Med"},{"issue":"11","key":"10.1016\/j.gim.2021.12.008_bib3","doi-asserted-by":"crossref","first-page":"1531","DOI":"10.1002\/humu.23609","article-title":"Quantifying the potential of functional evidence to reclassify variants of uncertain significance in the categorical and Bayesian interpretation frameworks","volume":"39","author":"Brnich","year":"2018","journal-title":"Hum Mutat"},{"issue":"1","key":"10.1016\/j.gim.2021.12.008_bib4","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/s13073-019-0690-2","article-title":"Recommendations for application of the functional evidence PS3\/BS3 criterion using the ACMG\/AMP sequence variant interpretation framework","volume":"12","author":"Brnich","year":"2019","journal-title":"Genome Med"},{"issue":"11","key":"10.1016\/j.gim.2021.12.008_bib5","doi-asserted-by":"crossref","first-page":"1525","DOI":"10.1002\/humu.23642","article-title":"ClinGen Sequence Variant Interpretation Working Group. Updated recommendation for the benign stand-alone ACMG\/AMP criterion","volume":"39","author":"Ghosh","year":"2018","journal-title":"Hum Mutat"},{"issue":"2","key":"10.1016\/j.gim.2021.12.008_bib6","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1038\/s41436-019-0686-8","article-title":"Technical standards for the interpretation and reporting of constitutional copy-number variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics (ACMG) and the Clinical Genome Resource (ClinGen)","volume":"22","author":"Riggs","year":"2020","journal-title":"Genet Med"},{"issue":"11","key":"10.1016\/j.gim.2021.12.008_bib7","doi-asserted-by":"crossref","first-page":"1517","DOI":"10.1002\/humu.23626","article-title":"Recommendations for interpreting the loss of function PVS1 ACMG\/AMP variant criterion","volume":"39","author":"Abou Tayoun","year":"2018","journal-title":"Hum Mutat"},{"issue":"9","key":"10.1016\/j.gim.2021.12.008_bib8","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1038\/s41436-018-0100-y","article-title":"Navigating the nuances of clinical sequence variant interpretation in Mendelian disease","volume":"20","author":"Strande","year":"2018","journal-title":"Genet Med"},{"issue":"9","key":"10.1016\/j.gim.2021.12.008_bib9","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1038\/gim.2017.210","article-title":"Modeling the ACMG\/AMP variant classification guidelines as a Bayesian classification framework","volume":"20","author":"Tavtigian","year":"2018","journal-title":"Genet Med"},{"issue":"11","key":"10.1016\/j.gim.2021.12.008_bib10","doi-asserted-by":"crossref","first-page":"1542","DOI":"10.1002\/humu.23640","article-title":"Integrating somatic variant data and biomarkers for germline variant classification in cancer predisposition genes","volume":"39","author":"Walsh","year":"2018","journal-title":"Hum Mutat"},{"issue":"6","key":"10.1016\/j.gim.2021.12.008_bib11","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1016\/j.ajhg.2016.04.003","article-title":"Consideration of cosegregation in the pathogenicity classification of genomic variants","volume":"98","author":"Jarvik","year":"2016","journal-title":"Am J Hum Genet"},{"issue":"11","key":"10.1016\/j.gim.2021.12.008_bib12","doi-asserted-by":"crossref","first-page":"1553","DOI":"10.1002\/humu.23650","article-title":"Specifications of the ACMG\/AMP variant curation guidelines for the analysis of germline CDH1 sequence variants","volume":"39","author":"Lee","year":"2018","journal-title":"Hum Mutat"},{"issue":"2","key":"10.1016\/j.gim.2021.12.008_bib13","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1182\/bloodadvances.2020003712","article-title":"Specifications of the variant curation guidelines for ITGA2B\/ITGB3: ClinGen platelet disorder variant curation panel","volume":"5","author":"Ross","year":"2021","journal-title":"Blood Adv"},{"issue":"3","key":"10.1016\/j.gim.2021.12.008_bib14","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1038\/gim.2017.218","article-title":"Adaptation and validation of the ACMG\/AMP variant classification framework for MYH7-associated inherited cardiomyopathies: recommendations by ClinGen\u2019s inherited cardiomyopathy expert panel","volume":"20","author":"Kelly","year":"2018","journal-title":"Genet Med"},{"issue":"11","key":"10.1016\/j.gim.2021.12.008_bib15","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.1002\/humu.23649","article-title":"Unique aspects of sequence variant interpretation for inborn errors of metabolism (IEM): the ClinGen IEM working group and the phenylalanine hydroxylase gene","volume":"39","author":"Zastrow","year":"2018","journal-title":"Hum Mutat"},{"issue":"11","key":"10.1016\/j.gim.2021.12.008_bib16","doi-asserted-by":"crossref","first-page":"1581","DOI":"10.1002\/humu.23636","article-title":"Gene-specific criteria for PTEN variant curation: recommendations from the ClinGen PTEN expert panel","volume":"39","author":"Mester","year":"2018","journal-title":"Hum Mutat"},{"issue":"20","key":"10.1016\/j.gim.2021.12.008_bib17","doi-asserted-by":"crossref","first-page":"2962","DOI":"10.1182\/bloodadvances.2019000644","article-title":"ClinGen myeloid malignancy variant curation expert panel recommendations for germline RUNX1 variants","volume":"3","author":"Luo","year":"2019","journal-title":"Blood Adv"},{"issue":"3","key":"10.1016\/j.gim.2021.12.008_bib18","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1002\/humu.24152","article-title":"Specifications of the ACMG\/AMP variant interpretation guidelines for germline TP53 variants","volume":"42","author":"Fortuno","year":"2021","journal-title":"Hum Mutat"},{"issue":"11","key":"10.1016\/j.gim.2021.12.008_bib19","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.1002\/humu.23630","article-title":"Expert specification of the ACMG\/AMP variant interpretation guidelines for genetic hearing loss","volume":"39","author":"Oza","year":"2018","journal-title":"Hum Mutat"},{"issue":"11","key":"10.1016\/j.gim.2021.12.008_bib20","doi-asserted-by":"crossref","first-page":"1334","DOI":"10.1038\/gim.2018.3","article-title":"ClinGen\u2019s RASopathy expert panel consensus methods for variant interpretation","volume":"20","author":"Gelb","year":"2018","journal-title":"Genet Med"},{"issue":"20","key":"10.1016\/j.gim.2021.12.008_bib21","doi-asserted-by":"crossref","first-page":"R225","DOI":"10.1093\/hmg\/ddab141","article-title":"Germline predisposition to haematopoietic malignancies","volume":"30","author":"Feurstein","year":"2021","journal-title":"Hum Mol Genet"},{"issue":"20","key":"10.1016\/j.gim.2021.12.008_bib22","doi-asserted-by":"crossref","first-page":"2391","DOI":"10.1182\/blood-2016-03-643544","article-title":"The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia","volume":"127","author":"Arber","year":"2016","journal-title":"Blood"},{"issue":"4","key":"10.1016\/j.gim.2021.12.008_bib23","doi-asserted-by":"crossref","first-page":"870","DOI":"10.3324\/haematol.2018.214221","article-title":"How I curate: applying American Society of Hematology-Clinical Genome Resource Myeloid Malignancy Variant Curation Expert Panel rules for RUNX1 variant curation for germline predisposition to myeloid malignancies","volume":"105","author":"Wu","year":"2020","journal-title":"Haematologica"},{"issue":"24","key":"10.1016\/j.gim.2021.12.008_bib24","doi-asserted-by":"crossref","first-page":"6199","DOI":"10.1182\/bloodadvances.2020003304","article-title":"Accurate germline RUNX1 variant interpretation and its clinical significance","volume":"4","author":"Feurstein","year":"2020","journal-title":"Blood Adv"},{"issue":"5","key":"10.1016\/j.gim.2021.12.008_bib25","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1016\/j.ccell.2015.03.017","article-title":"Inherited and somatic defects in DDX41 in myeloid neoplasms","volume":"27","author":"Polprasert","year":"2015","journal-title":"Cancer Cell"},{"issue":"8","key":"10.1016\/j.gim.2021.12.008_bib26","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1182\/blood-2015-10-676098","article-title":"Novel germ line DDX41 mutations define families with a lower age of MDS\/AML onset and lymphoid malignancies","volume":"127","author":"Lewinsohn","year":"2016","journal-title":"Blood"},{"issue":"17","key":"10.1016\/j.gim.2021.12.008_bib27","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1182\/blood.2019000909","article-title":"Germline DDX41 mutations define a significant entity within adult MDS\/AML patients","volume":"134","author":"S\u00e9bert","year":"2019","journal-title":"Blood"},{"key":"10.1016\/j.gim.2021.12.008_bib28","author":"Howlader"},{"issue":"10","key":"10.1016\/j.gim.2021.12.008_bib29","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1038\/gim.2017.26","article-title":"Using high-resolution variant frequencies to empower clinical genome interpretation","volume":"19","author":"Whiffin","year":"2017","journal-title":"Genet Med"},{"issue":"10","key":"10.1016\/j.gim.2021.12.008_bib30","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1182\/blood-2015-05-647172","article-title":"Disease evolution and outcomes in familial AML with germline CEBPA mutations","volume":"126","author":"Tawana","year":"2015","journal-title":"Blood"},{"issue":"3","key":"10.1016\/j.gim.2021.12.008_bib31","doi-asserted-by":"crossref","first-page":"529","DOI":"10.3324\/haematol.2016.151910","article-title":"CEBPA \u2013double-mutated acute myeloid leukemia displays a unique phenotypic profile: a reliable screening method and insight into biological features","volume":"102","author":"Mannelli","year":"2017","journal-title":"Haematologica"},{"issue":"8","key":"10.1016\/j.gim.2021.12.008_bib32","doi-asserted-by":"crossref","first-page":"2469","DOI":"10.1182\/blood-2010-09-307280","article-title":"Prognostic impact, concurrent genetic mutations, and gene expression features of AML with CEBPA mutations in a cohort of 1182 cytogenetically normal AML patients: further evidence for CEBPA double mutant AML as a distinctive disease entity","volume":"117","author":"Taskesen","year":"2011","journal-title":"Blood"},{"issue":"31","key":"10.1016\/j.gim.2021.12.008_bib33","doi-asserted-by":"crossref","first-page":"5088","DOI":"10.1200\/JCO.2008.16.5563","article-title":"Somatic CEBPA mutations are a frequent second event in families with germline CEBPA mutations and familial acute myeloid leukemia","volume":"26","author":"Pabst","year":"2008","journal-title":"J\u00a0Clin Oncol"},{"issue":"3","key":"10.1016\/j.gim.2021.12.008_bib34","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/j.cell.2018.12.015","article-title":"Predicting splicing from primary sequence with deep learning","volume":"176","author":"Jaganathan","year":"2019","journal-title":"Cell"},{"issue":"1","key":"10.1016\/j.gim.2021.12.008_bib35","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1186\/s13073-020-00737-2","article-title":"Clinical impact of splicing in neurodevelopmental disorders","volume":"12","author":"Sanders","year":"2020","journal-title":"Genome Med"},{"issue":"6","key":"10.1016\/j.gim.2021.12.008_bib36","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1038\/s41436-020-0766-9","article-title":"Blood RNA analysis can increase clinical diagnostic rate and resolve variants of uncertain significance","volume":"22","author":"Wai","year":"2020","journal-title":"Genet Med"},{"issue":"8","key":"10.1016\/j.gim.2021.12.008_bib37","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1002\/humu.22101","article-title":"Guidelines for splicing analysis in molecular diagnosis derived from a set of 327 combined in silico\/in\u00a0vitro studies on BRCA1 and BRCA2 variants","volume":"33","author":"Houdayer","year":"2012","journal-title":"Hum Mutat"},{"issue":"22","key":"10.1016\/j.gim.2021.12.008_bib38","doi-asserted-by":"crossref","first-page":"13534","DOI":"10.1093\/nar\/gku1206","article-title":"In silico prediction of splice-altering single nucleotide variants in the human genome","volume":"42","author":"Jian","year":"2014","journal-title":"Nucleic Acids Res"},{"issue":"15","key":"10.1016\/j.gim.2021.12.008_bib39","doi-asserted-by":"crossref","first-page":"7913","DOI":"10.1093\/nar\/gky372","article-title":"Novel diagnostic tool for prediction of variant spliceogenicity derived from a set of 395 combined in silico\/in\u00a0vitro studies: an international collaborative effort","volume":"46","author":"Leman","year":"2018","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.gim.2021.12.008_bib40","doi-asserted-by":"crossref","DOI":"10.1155\/2016\/5614058","article-title":"Evaluation of bioinformatic programmes for the analysis of variants within splice site consensus regions","volume":"2016","author":"Tang","year":"2016","journal-title":"Adv Bioinformatics"},{"issue":"1","key":"10.1016\/j.gim.2021.12.008_bib41","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/s13073-017-0403-7","article-title":"Pathogenic variant burden in the ExAC database: an empirical approach to evaluating population data for clinical variant interpretation","volume":"9","author":"Kobayashi","year":"2017","journal-title":"Genome Med"},{"issue":"1","key":"10.1016\/j.gim.2021.12.008_bib42","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1002\/humu.23673","article-title":"Variable population prevalence estimates of germline TP53 variants: a gnomAD-based analysis","volume":"40","author":"de Andrade","year":"2019","journal-title":"Hum Mutat"},{"issue":"22","key":"10.1016\/j.gim.2021.12.008_bib43","doi-asserted-by":"crossref","first-page":"3404","DOI":"10.1182\/bloodadvances.2018020222","article-title":"Clinical consequences of clonal hematopoiesis of indeterminate potential","volume":"2","author":"Steensma","year":"2018","journal-title":"Blood Adv"},{"issue":"7616","key":"10.1016\/j.gim.2021.12.008_bib44","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1038\/nature19057","article-title":"Analysis of protein-coding genetic variation in 60,706 humans","volume":"536","author":"Lek","year":"2016","journal-title":"Nature"},{"issue":"2","key":"10.1016\/j.gim.2021.12.008_bib45","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/j.ajhg.2018.12.020","article-title":"Improved pathogenic variant localization via a hierarchical model of sub-regional intolerance","volume":"104","author":"Hayeck","year":"2019","journal-title":"Am J Hum Genet"},{"issue":"1","key":"10.1016\/j.gim.2021.12.008_bib46","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/s13059-016-0869-4","article-title":"The intolerance to functional genetic variation of protein domains predicts the localization of pathogenic mutations within genes","volume":"17","author":"Gussow","year":"2016","journal-title":"Genome Biol"},{"issue":"1","key":"10.1016\/j.gim.2021.12.008_bib47","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1038\/s41588-018-0294-6","article-title":"A\u00a0map of constrained coding regions in the human genome","volume":"51","author":"Havrilla","year":"2019","journal-title":"Nat Genet"},{"issue":"24","key":"10.1016\/j.gim.2021.12.008_bib48","doi-asserted-by":"crossref","first-page":"6673","DOI":"10.1182\/blood-2011-02-336537","article-title":"Mutations in ANKRD26 are responsible for a frequent form of inherited thrombocytopenia: analysis of 78 patients from 21 families","volume":"117","author":"Noris","year":"2011","journal-title":"Blood"},{"issue":"11","key":"10.1016\/j.gim.2021.12.008_bib49","doi-asserted-by":"crossref","first-page":"1987","DOI":"10.1182\/blood-2013-04-499319","article-title":"ANKRD26-related thrombocytopenia and myeloid malignancies","volume":"122","author":"Noris","year":"2013","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.gim.2021.12.008_bib50","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.ajhg.2010.12.006","article-title":"Mutations in the 5\u2032 UTR of ANKRD26, the ankirin repeat domain 26 gene, cause an autosomal-dominant form of inherited thrombocytopenia, THC2","volume":"88","author":"Pippucci","year":"2011","journal-title":"Am J Hum Genet"},{"issue":"2","key":"10.1016\/j.gim.2021.12.008_bib51","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1172\/JCI71861","article-title":"Thrombocytopenia-associated mutations in the ANKRD26 regulatory region induce MAPK hyperactivation","volume":"124","author":"Bluteau","year":"2014","journal-title":"J\u00a0Clin Invest"},{"issue":"1","key":"10.1016\/j.gim.2021.12.008_bib52","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1073\/pnas.0136770100","article-title":"Evidence for the widespread coupling of alternative splicing and nonsense-mediated mRNA decay in humans","volume":"100","author":"Lewis","year":"2003","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"10.1016\/j.gim.2021.12.008_bib53","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1146\/annurev.biochem.76.050106.093909","article-title":"The nonsense-mediated decay RNA surveillance pathway","volume":"76","author":"Chang","year":"2007","journal-title":"Annu Rev Biochem"},{"key":"10.1016\/j.gim.2021.12.008_bib54","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1093\/gbe\/evq058","article-title":"Connections between alternative transcription and alternative splicing in mammals","volume":"2","author":"Shabalina","year":"2010","journal-title":"Genome Biol Evol"},{"issue":"6","key":"10.1016\/j.gim.2021.12.008_bib55","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1084\/jem.20151183","article-title":"A\u00a0nonsense mutation in the DNA repair factor Hebo causes mild bone marrow failure and microcephaly","volume":"213","author":"Zhang","year":"2016","journal-title":"J\u00a0Exp Med"},{"issue":"30","key":"10.1016\/j.gim.2021.12.008_bib56","doi-asserted-by":"crossref","first-page":"7777","DOI":"10.1073\/pnas.1803275115","article-title":"Genome instability is a consequence of transcription deficiency in patients with bone marrow failure harboring biallelic ERCC6L2 variants","volume":"115","author":"Tummala","year":"2018","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"2","key":"10.1016\/j.gim.2021.12.008_bib57","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/j.ajhg.2014.01.007","article-title":"ERCC6L2 mutations link a distinct bone-marrow-failure syndrome to DNA repair and mitochondrial function","volume":"94","author":"Tummala","year":"2014","journal-title":"Am J Hum Genet"},{"issue":"4","key":"10.1016\/j.gim.2021.12.008_bib58","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1016\/j.ajhg.2016.08.016","article-title":"REVEL: an ensemble method for predicting the pathogenicity of rare missense variants","volume":"99","author":"Ioannidis","year":"2016","journal-title":"Am J Hum Genet"},{"issue":"2","key":"10.1016\/j.gim.2021.12.008_bib59","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pcbi.1006481","article-title":"How good are pathogenicity predictors in detecting benign variants?","volume":"15","author":"Niroula","year":"2019","journal-title":"PLoS Comput Biol"},{"issue":"1","key":"10.1016\/j.gim.2021.12.008_bib60","doi-asserted-by":"crossref","first-page":"56","DOI":"10.2174\/1389202921666200210141701","article-title":"The experimentally obtained functional impact assessments of 5\u2032 splice site GT\u2032GC variants differ markedly from those predicted","volume":"21","author":"Chen","year":"2020","journal-title":"Curr Genomics"},{"issue":"5","key":"10.1016\/j.gim.2021.12.008_bib61","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1038\/ng.3253","article-title":"Germline mutations in ETV6 are associated with thrombocytopenia, red cell macrocytosis and predisposition to lymphoblastic leukemia","volume":"47","author":"Noetzli","year":"2015","journal-title":"Nat Genet"},{"issue":"2","key":"10.1016\/j.gim.2021.12.008_bib62","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1007\/s12185-020-02885-y","article-title":"Functional characterization of a germline ETV6 variant associated with inherited thrombocytopenia, acute lymphoblastic leukemia, and salivary gland carcinoma in childhood","volume":"112","author":"Yoshino","year":"2020","journal-title":"Int J Hematol"},{"issue":"2","key":"10.1016\/j.gim.2021.12.008_bib63","doi-asserted-by":"crossref","first-page":"282","DOI":"10.3324\/haematol.2016.147694","article-title":"Germline variants in ETV6 underlie reduced platelet formation, platelet dysfunction and increased levels of circulating CD34+ progenitors","volume":"102","author":"Poggi","year":"2017","journal-title":"Haematologica"},{"issue":"2","key":"10.1016\/j.gim.2021.12.008_bib64","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1038\/ng.3177","article-title":"Germline ETV6 mutations in familial thrombocytopenia and hematologic malignancy","volume":"47","author":"Zhang","year":"2015","journal-title":"Nat Genet"},{"issue":"6","key":"10.1016\/j.gim.2021.12.008_bib65","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pgen.1005262","article-title":"Germline ETV6 mutations confer susceptibility to acute lymphoblastic leukemia and thrombocytopenia","volume":"11","author":"Topka","year":"2015","journal-title":"PLoS Genet"},{"issue":"8","key":"10.1016\/j.gim.2021.12.008_bib66","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1084\/jem.20151618","article-title":"Mutations in STN1 cause Coats plus syndrome and are associated with genomic and telomere defects","volume":"213","author":"Simon","year":"2016","journal-title":"J\u00a0Exp Med"},{"issue":"3","key":"10.1016\/j.gim.2021.12.008_bib67","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1038\/ng.1084","article-title":"Mutations in CTC1, encoding conserved telomere maintenance component 1, cause Coats plus","volume":"44","author":"Anderson","year":"2012","journal-title":"Nat Genet"},{"issue":"7","key":"10.1016\/j.gim.2021.12.008_bib68","doi-asserted-by":"crossref","DOI":"10.15252\/msb.20199380","article-title":"Using deep mutational scanning to benchmark variant effect predictors and identify disease mutations","volume":"16","author":"Livesey","year":"2020","journal-title":"Mol Syst Biol"}],"container-title":["Genetics in Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1098360021054678?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1098360021054678?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T01:52:15Z","timestamp":1761097935000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1098360021054678"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4]]},"references-count":68,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2022,4]]}},"alternative-id":["S1098360021054678"],"URL":"https:\/\/doi.org\/10.1016\/j.gim.2021.12.008","relation":{},"ISSN":["1098-3600"],"issn-type":[{"value":"1098-3600","type":"print"}],"subject":[],"published":{"date-parts":[[2022,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A practical guide to interpreting germline variants that drive hematopoietic malignancies, bone marrow failure, and chronic cytopenias","name":"articletitle","label":"Article Title"},{"value":"Genetics in Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.gim.2021.12.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 by American College of Medical Genetics and Genomics. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}